Before We Start
A fungus you can't culture, diagnosed by staining instead
Most organisms get identified by growing them in culture. Pneumocystis can't be cultured at all — which is exactly why the diagnostic approach here looks completely different from most other infections covered in this section.
💡 Memory Trick
PCP: AIDS-defining illness at CD4 below 200. Diagnosed via BAL with GMS stain, since standard culture won't work. Bilateral infiltrates plus a markedly elevated LDH complete the classic picture.
The Key Points
Classification, the culture problem, the classic presentation, and treatment
Pj
Pneumocystis jirovecii — reclassified as a fungus
Pneumocystis jirovecii was once thought to be a protozoan, but is now classified as a fungus. It causes pneumonia specifically in immunocompromised patients, and is considered an AIDS-defining illness when it occurs in a patient with CD4 below 200.
🦠 Older reference materials sometimes still describe Pneumocystis as a protozoan — worth double-checking any source's classification against the current fungal reclassification specifically.
Dx
Diagnosis — cannot be cultured, so staining is required instead
Pneumocystis cannot be grown in standard culture at all. Diagnosis instead requires bronchoalveolar lavage (BAL) with GMS (Gomori methenamine silver) staining, which shows characteristic cup-shaped cysts under the microscope.
🦠 A patient with a suspected PCP infection needs a BAL sample specifically sent for GMS staining, since a standard bacterial culture order would come back uninformative regardless of whether the organism is actually present.
Sx
Presentation — progressive dyspnea and bat-wing infiltrates
Patients develop progressive dyspnea, a dry (non-productive) cough, fever, and hypoxia — often more severe than the chest X-ray appearance would suggest. The classic imaging finding is bilateral, diffuse interstitial infiltrates, sometimes described as a "bat-wing" pattern. LDH is typically markedly elevated and correlates directly with disease severity.
🦠 A patient whose hypoxia seems disproportionately severe relative to how the chest X-ray actually looks is a subtle but real clue toward PCP, where clinical severity often outpaces radiographic findings.
Tx
Treatment — TMP-SMX, plus steroids if significantly hypoxic
First-line treatment is high-dose TMP-SMX for 21 days. If the patient is significantly hypoxic (PaO₂ below 70 mmHg), corticosteroids are added to reduce inflammation and improve survival. TMP-SMX is also used as prophylaxis in any patient with CD4 below 200, preventing the infection before it starts.
🦠 A patient with AIDS and a CD4 count of 150 develops progressive shortness of breath over several days along with a dry cough; CXR shows bilateral interstitial infiltrates and labs show a markedly elevated LDH — this is PCP, treated with high-dose TMP-SMX, with steroids added given the degree of hypoxia.
🏥 Applied Scenario
A patient with AIDS and a CD4 count of 150 develops progressive shortness of breath, a dry cough, and low-grade fever, with a CXR showing bilateral diffuse interstitial infiltrates, markedly elevated LDH, and a PaO₂ of 62 mmHg.
Step 1
Establish the diagnosis: What's the diagnosis, and how aggressively should it be treated? The CD4 count under 200, the bilateral infiltrate pattern, and the elevated LDH all point to PCP.
Step 2
Determine whether steroids are indicated: Given the PaO₂ of 62 (below the 70 mmHg threshold), corticosteroids should be added alongside high-dose TMP-SMX — this combination reduces inflammation and has been shown to improve survival specifically in more hypoxic patients.
Step 3
Recognize the severity threshold's specific role: The 70 mmHg PaO₂ cutoff isn't arbitrary — it's the specific point where the evidence supports adding steroids, meaning this patient's hypoxia level directly changes the treatment plan, not just the urgency of care.
Step 4
Conclusion: Treatment intensity for PCP scales directly with a specific, checkable lab value (PaO₂), rather than being a uniform one-size regimen regardless of severity.
📌 Exam Application
Exams test the CD4 threshold for PCP as an AIDS-defining illness (below 200), the diagnostic approach (BAL with GMS stain, since it cannot be cultured), the classic presentation (bilateral infiltrates, high LDH), and the treatment structure — TMP-SMX for 21 days, with steroids added if PaO₂ is below 70 mmHg, and prophylactic TMP-SMX for any patient with CD4 below 200.
⚠️ The Trap — Forgetting Pneumocystis Is a Fungus and Cannot Be Cultured
The most common trap is forgetting that Pneumocystis jirovecii is now classified as a fungus, not a protozoan (an older classification some materials still reflect) — and forgetting that it cannot be cultured, meaning diagnosis relies specifically on staining a BAL sample rather than growing the organism in the lab the way most other infections are confirmed.
✓ Quick Self-Test
Answer before checking:
1. What type of organism is Pneumocystis jirovecii currently classified as?
2. At what CD4 count is PCP considered an AIDS-defining illness?
3. How is PCP diagnosed, given that it cannot be cultured?
4. What is the classic chest X-ray finding in PCP, and what lab value correlates with severity?
5. When are corticosteroids added to PCP treatment, and what is the standard treatment?
Answers:
1. A fungus — it was previously thought to be a protozoan.
2. Below 200.
3. Via bronchoalveolar lavage (BAL) with GMS (Gomori methenamine silver) staining, showing cup-shaped cysts.
4. Bilateral, diffuse interstitial infiltrates ("bat-wing" pattern); LDH is markedly elevated and correlates with severity.
5. Corticosteroids are added if PaO₂ is below 70 mmHg; standard treatment is high-dose TMP-SMX for 21 days.